Abstract:Severe peripheral nerve injury (PNI) often leads to significant movement disorders and intractable pain. Therefore, promoting nerve regeneration while avoiding neuropathic pain is crucial for the clinical treatment of PNI patients. However, established animal models for peripheral neuropathy fail to accurately recapitulate the clinical features of PNI. Additionally, researchers usually investigate neuropathic pain and axonal regeneration separately, leaving the intrinsic relationship between the development of neuropathic pain and nerve regeneration after PNI unclear. To explore the underlying connections between pain and regeneration after PNI and provide potential molecular targets, we performed single-cell RNA sequencing and functional verification in an established rat model, allowing simultaneous study of the neuropathic pain and axonal regeneration after PNI. First, a novel rat model named spared nerve crush (SNC) was created. In this model, two branches of the sciatic nerve were crushed, but the epineurium remained unsevered. This model successfully recapitulated both neuropathic pain and axonal regeneration after PNI, allowing for the study of the intrinsic link between these two crucial biological processes. Dorsal root ganglions (DRGs) from SNC and naïve rats at various time points after SNC were collected for single-cell RNA sequencing (scRNA-seq). After matching all scRNA-seq data to the 7 known DRG types, we discovered that the PEP1 and PEP3 DRG neuron subtypes increased in crushed and uncrushed DRG separately after SNC. Using experimental design scRNA-seq processing (EDSSP), we identified Adcyap1 as a potential gene contributing to both pain and nerve regeneration. Indeed, repeated intrathecal administration of PACAP38 mitigated pain and facilitated axonal regeneration, while Adcyap1 siRNA or PACAP6-38, an antagonist of PAC1R (a receptor of PACAP38) led to both mechanical hyperalgesia and delayed DRG axon regeneration in SNC rats. Moreover, these effects can be reversed by repeated intrathecal administration of PACAP38 in the acute phase but not the late phase after PNI, resulting in alleviated pain and promoted axonal regeneration. Our study reveals that Adcyap1 is an intrinsic protective factor linking neuropathic pain and axonal regeneration following PNI. This finding provides new potential targets and strategies for early therapeutic intervention of PNI.

Effects of Sigma-1 Receptor Ligands on Peripheral Nerve Regeneration

P2Y2 Receptor Mediated Neuronal Regeneration and Angiogenesis to Affect Functional Recovery in Rats with Spinal Cord Injury

Sigma-1 Receptors Control Neuropathic Pain and Peripheral Neuroinflammation After Nerve Injury in Female Mice: A Transcriptomic Study

Critical role of sigma-1 receptors in central neuropathic pain-related behaviours after mild spinal cord injury in mice

Interleukin-1 beta promotes sensory nerve regeneration after sciatic nerve injury

Effect of Active Notch Signaling System on the Early Repair of Rat Sciatic Nerve Injury

Role and Interplay of Different Signaling Pathways Involved in Sciatic Nerve Regeneration

Involvement of CXCL10 in Neuronal Damage under the Condition of Spinal Cord Injury and the Potential Therapeutic Effect of Nrg1

Effects of Regenerative Peripheral Nerve Interface on Dorsal Root Ganglia Neurons Following Peripheral Axotomy

Genomic Action of Sigma-1 Receptor Chaperone Relates to Neuropathic Pain

In Situ Deactivation of Interleukin-6 Enhances Early Peripheral Nerve Regeneration in a Murine Injury Model

Inhibition of the Nogo-pathway in experimental spinal cord injury: a meta-analysis of 76 experimental treatments

Pathways regulating modality-specific axonal regeneration in peripheral nerve

Sigma‐1 Receptor Agonist Increases Axon Outgrowth of Hippocampal Neurons Via Voltage‐gated Calcium Ions Channels

Changes in proteins related to early nerve repair in a rat model of sciatic nerve injury

Controlled local release of PPARγ agonists from biomaterials to treat peripheral nerve injury

Improving peripheral nerve regeneration: from molecular mechanisms to potential therapeutic targets

The Mechanisms Mediated by α7 Acetylcholine Nicotinic Receptors May Contribute to Peripheral Nerve Regeneration

Sigma-1 receptor inhibition reverses acute inflammatory hyperalgesia in mice: role of peripheral sigma-1 receptors

Unveiling Adcyap1 As a Protective Factor Linking Pain and Nerve Regeneration Through Single-Cell RNA Sequencing of Rat Dorsal Root Ganglion Neurons.

Neutrophil Peptide-1 Promotes the Repair of Sciatic Nerve Injury Through the Expression of Proteins Related to Nerve Regeneration